Skip to main content

Advertisement

SpringerLink
Log in

A study on the relationship between the prognosis of chronic active hepatitis and the HBV associated antigen/antibody systems

  • Original Articles
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

The relationship between the prognosis of the disease based on liver histology and HB virus (HBV) associated antigen/antibody systems was investigated in twenty seven patients with chronic active hepatitis (CAH). These patients were followed up over extended periods with mean duration of 44.3 months. On initial liver biopsy five of twelve patients with CAH with spotty or focal necrosis were HBs antigen (HBsAg) positive, as were also five of six patients with sublobular necrosis and six of nine patients with lobular disorganization. Most of the HBsAg negative patients were anti-HBs or anti-HBc positive: HBV associated antigen or antibody was completely undetectable in only three of the twenty seven patients. There was no difference in the frequency of progression to liver cirrhosis (LC) between the sixteen HBsAg positive and the eleven HBsAg negative patients with CAH. On the other hand, progression to LC occurred in only one of seven HBe antigen (HBeAg) negative patients, compared to four of nine HBeAg positive patients, who were HBsAg positive. There were four patients who were HBeAg positive initially but then became HBeAg negative in the course of observation. LC developed in two of these four patients.

These results suggest that in HBsAg positive patients with CAH the presence or absence of HBeAg and the variation in its level can provide useful indicators of the prognosis of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sherlock S: Chronic hepatitis, in “Diseases of the Liver and Biliary System” 5th Ed Blackwell Scientific Publications, London, 1975, p 425

    Google Scholar 

  2. Rakala J, et al: Hepatitis A virus infection in fulminant and chronic active hepatitis. Gastroenterology 74: 879, 1978

    Google Scholar 

  3. Hoofnagle JH, et al: Transmission of non-A, non-B hepatitis. Ann Intern Med 87: 14, 1977

    PubMed  CAS  Google Scholar 

  4. Zuckerman AJ: The epidemiology of viral hepatitis, in “Human Viral Hepatitis” 2nd Ed North-Holland Publishing Company, New York, 1975, p 33

    Google Scholar 

  5. De Groote J, et al: Long-term follow-up of chronic active hepatitis of moderate severity. Gut 19: 510, 1978

    Article  PubMed  Google Scholar 

  6. Schalm SW, et al: Contrasting features and responses to treatment of chronic active liver diseases with and without hepatitis Bs antigen. Gut 17: 781, 1976

    Article  PubMed  CAS  Google Scholar 

  7. Chadwick RG, et al: Chronic persistent hepatitis: hepatitis B virus markers and histological follow-up. Gut 20: 372, 1979

    Article  PubMed  CAS  Google Scholar 

  8. Harada T, et al: Panel discussion (2): Prognosis of chronic liver diseases. Gastroenterol Jpn 14: 640, 1979

    Google Scholar 

  9. De Groote, et al: A classification of chronic hepatitis. Lancet 2: 626, 1968

    PubMed  Google Scholar 

  10. Leevy CM, et al: Chronic hepatitis, in “Diseases of the Liver and Biliary Tract: Standarization of Nomenclature, Diagnostic Criteria and Diagnostic Methodology” Castle House Publication Ltd, London p 9, 1979

    Google Scholar 

  11. Boyer JL, et al: Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (Subacute hepatic necrosis). New Engl J Med 283: 1063, 1970

    Article  PubMed  CAS  Google Scholar 

  12. Schalm SW, et al: Severe chronic active liver disease, prognostic significance of initial morphologic patterns. Am J Dis 22: 973, 1977

    Article  CAS  Google Scholar 

  13. Baggenstoss AH, et al: Chronic active liver disease, the range of histological lesions, their response to treatment, and evolution. Human Pathol 3: 183, 1972

    CAS  Google Scholar 

  14. Kosaka Y, et al: Prognostic evaluation of chronic hepatitis with particular reference to the findings of repeated liver biopsy. Jpn J Gastroent 78: 667, 1981

    CAS  Google Scholar 

  15. Giusti G, et al: Treatment of chronic active hepatitis with either prednisolone or corticotrophin. Acta Hepatogastroenterol 24: 131, 1977

    CAS  Google Scholar 

  16. Jorge AD, et al: Therapeutic evaluation of chronic aggressive hepatitis and its relation to the Australia antigen. Acta Hepatogastroenterol 25: 179, 1978

    CAS  Google Scholar 

  17. Christoffersen P, et al: Histological changes on liver biopsies from patients with chronic hepatitis. Acta Pathol Microbiol Scand, Sec A 82: 539, 1974

    CAS  Google Scholar 

  18. Magnius LO, et al: New specificies in Australia antigen positive sera distinct from the LeBouvier determinants. J Immunol 109: 1017, 1972

    PubMed  CAS  Google Scholar 

  19. Furuta S, et al: Clinical significance of e-antigen/antibody, with special reference to HBc antigen in the liver. GastroenteroI Jpn 12: 460, 1977

    CAS  Google Scholar 

  20. Sheikh NEL, et al: e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen. Brit Med J 4: 252, 1975

    Article  PubMed  Google Scholar 

  21. Hess G, et al: e-System and intrahepatocellular HBcAg and HBsAg in HBsAg positive patients with liver diseases and healthy carriers. Scand J Gastroenterol 12: 325, 1977

    Article  PubMed  CAS  Google Scholar 

  22. Fay O, et al: Prognostic implications of the e antigen of hepatitis B virus. JAMA 238: 2501, 1977

    Article  PubMed  CAS  Google Scholar 

  23. Realdi G, et al: Seroconversion from hepatitis Be antigen to anti-HBe in chronic hepatitis. Gastroenterology 79: 195, 1980

    PubMed  CAS  Google Scholar 

  24. Vogten AJM: Behaviour of e antigen and antibody during chronic active liver disease relation to HB antigen-antibody system and prognosis. Lancet 2: 126, 1977

    Google Scholar 

  25. Nordenfelt E, et al: Dane particle-associated DNA polymerase and e antigen: relation to chronic hepatitis among carriers of hepatitis B surface antigen. Eur J Inf Dis 134:85, 1976

    CAS  Google Scholar 

  26. Niermeijer P, et al: Hepatitis B antigen and antibodies in chronic hepatitis. New Engl J Med 231: 269, 1979

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu-City, 514, Mie-Ken, Japan

    Yoshitane Kosaka M.D., Yukihiko Tameda M.D., Yoshiro Okuda M.D., Kojiro Takase M.D., Hiroki Sawa M.D. & Hideo Takezawa M.D.

Authors
  1. Yoshitane Kosaka M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yukihiko Tameda M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshiro Okuda M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kojiro Takase M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroki Sawa M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hideo Takezawa M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kosaka, Y., Tameda, Y., Okuda, Y. et al. A study on the relationship between the prognosis of chronic active hepatitis and the HBV associated antigen/antibody systems. Gastroenterol Jpn 16, 592–599 (1981). https://doi.org/10.1007/BF02813794

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02813794

Key Words

Search

Navigation